US Broker Ratings

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring the 130% Upside Potential

Beam Therapeutics Inc. (BEAM), a pioneering force in the biotechnology sector, is turning heads with its impressive potential upside of 130.47%. With a current market cap of $1.92 billion, the..

Opko Health, Inc. (OPK) Stock Analysis: A High-Risk Play with 214% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, is attracting attention from individual investors due to its significant potential upside. With a market capitalization of $1.01..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 45% Potential Upside with Strong Buy Ratings

Ocular Therapeutix, Inc. (OCUL) is capturing investor attention with its promising potential upside of 45.07% and unanimous buy recommendations from analysts. As a key player in the biotechnology sector, this..

Phreesia, Inc. (PHR) Stock Analysis: Strong Buy Ratings and Potential 18% Upside

Phreesia, Inc. (NASDAQ: PHR) is making waves in the healthcare sector with its innovative approach to health information services, offering a comprehensive SaaS-based software and payment platform. With a market..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A 39% Potential Upside in the Biotech Arena

For investors seeking exposure in the healthcare sector, Scholar Rock Holding Corporation (NASDAQ: SRRK) presents a compelling opportunity with a robust potential upside of 39.23%. This American biotechnology company, headquartered..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a Potential 8.5% Upside Amid Robust CNS Innovation

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a notable player in the healthcare sector, is making waves in the biopharmaceutical landscape with its specialized focus on central nervous system (CNS) diseases. With..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 39% Potential Upside

Pediatrix Medical Group, Inc. (MD) stands as a notable entity within the healthcare sector, specifically in the medical care facilities industry. This U.S.-based company, with a market capitalization of $1.06..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring a 135% Potential Upside in the Biotech Sector

Investors eyeing the biotech sector might want to take a closer look at Amicus Therapeutics, Inc. (NASDAQ: FOLD), which stands out with a compelling potential upside of 135.59%. As a..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unveiling a Potential 31% Upside in the Medical Device Sector

Establishment Labs Holdings Inc (NASDAQ: ESTA), a Costa Rican-based medical technology company, is making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of..

MannKind Corporation (MNKD): Investor Outlook Shows 132% Potential Upside in Biotech Sector

MannKind Corporation (NASDAQ: MNKD) is making waves in the biotechnology sector with its promising potential for growth and innovation in therapeutic products for endocrine and orphan lung diseases. With a..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 108.93% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a prominent player in the healthcare sector, is drawing interest from investors with a substantial market cap of $1.34 billion. Specializing in the development and..

Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 48% Potential Upside in Synthetic DNA Innovation

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector’s diagnostics and research industry, has been making waves with its cutting-edge synthetic DNA-based products. With a market capitalization..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: 66% Upside Potential Amidst Biotech Innovation

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a promising player in the biotechnology sector, is capturing the attention of investors with its robust R&D pipeline and potential for significant upside. Based in..

Novavax, Inc. (NVAX) Investor Outlook: Exploring Potential Upside Despite Volatile Valuation

Novavax, Inc. (NASDAQ: NVAX), a pioneering biotechnology company, is capturing the attention of investors with its ambitious vaccine development initiatives and a potential upside nearing 94.71%. Despite its current market..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 65.84% Potential Upside in the Healthcare Diagnostics Sector

Veracyte, Inc. (VCYT), a prominent player in the healthcare diagnostics sector, is capturing the attention of investors with a compelling potential upside of 65.84%, based on the average target price..

Immunocore Holdings plc (IMCR) Stock Analysis: Discovering the 91.97% Potential Upside in Biotechnology

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology company, is capturing investor interest with a promising potential upside of 91.97%, as indicated by its average target price of $62.45. With..

Enovis Corporation (ENOV) Stock Analysis: Unpacking a 111% Upside Potential in the Healthcare Sector

Enovis Corporation (NYSE: ENOV) is catching the eye of investors with its promising potential upside and strategic positioning in the healthcare sector. Operating primarily in the medical devices industry, the..

Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 106% Upside Potential in the Healthcare Sector

Astrana Health Inc. (ASTH), a prominent player in the healthcare management industry, is drawing significant attention from investors with its compelling potential upside of 106.68%. Headquartered in Alhambra, California, Astrana..

Metsera, Inc. (MTSR) Stock Analysis: A Promising 66% Upside in the Healthcare Biotech Sector

Metsera, Inc. (MTSR), a burgeoning player in the healthcare biotechnology sector, has caught the attention of investors with its innovative approach to tackling obesity and related diseases. Based in New..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Is There a 116% Upside Potential for This Healthcare Innovator?

LifeStance Health Group, Inc. (LFST), a significant player in the healthcare sector, is gaining attention from investors with a remarkable potential upside of 116.35%. As a provider of outpatient mental..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds